The need for accurate epidemiology data to drive a higher success rate with Health Technology Assessments

Most drug or device launches today require a health economic valuation often in the form of a Health Technology Assessment (HTA) to satisfy payers that the new ‘technology’ is advantageous for the health system. Most HTAs include epidemiology data in some form. This is often included in order to understand the impact of the technology…